Delivery Order SPE2DB20D3101-SPE2DB24FRJT5

Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of LIDOCAINE 5% PATCH 30S. The contract has an award value of $1,500.80 and a completion date of March 27, 2025. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,888.88 firm fixed-price delivery order is for the procurement of 4565191428 - LIDOCAINE 5% PATCH 30S, with a completion date of July 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,888.89 firm fixed price delivery order is for the procurement of LIDOCAINE 5% PATCH 30S, a medical product. The contract has an ultimate completion date of April 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,114.76 firm fixed price delivery order is for the supply of 4564949981 LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has a completion date of June 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The $9,349.77 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 13, 2025, with a completion date of February 14, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,526.49 firm fixed-price delivery order is for 4559878888 LIDOCAINE 5% PATCH 30S, with a completion date of February 9, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The federal contract award is for the delivery of 4564960173 - LIDOCAINE 5% PATCH 30S to the U.S. Defense agency, specifically the Medical Supply Chain program. The award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, and has a ceiling value of $4,137.60. The contract is a firm fixed price Delivery Order with a completion date of June 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,183.88 firm fixed-price delivery order is for the supply of 4566676121 - LIDOCAINE 5% PATCH 30S. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for a delivery order with a ceiling value of $3,188.69 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract covers the procurement of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a period of performance through December 17, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,113.26 firm fixed-price delivery order is for the supply of 4565019958 LIDOCAINE 5% PATCH 30S. The contract has an ultimate completion date of June 28, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRJT5
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of 4564544784 LIDOCAINE 5% PATCH 30S to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The firm-fixed-price contract award, valued at $7,083.78, has a completion date of May 9, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order falls under that broader IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:13 PM